NEW YORK, Oct. 30 – Motorola announced Monday it has completed development of its eSensor low-density clinical microarray, and will begin manufacturing this instrument in the second quarter of next year.

The company’s Clinical Micro Sensors business unit is making the sensors to do DNA testing for health care, agriculture, and environmental monitoring, as previously reported in GenomeWeb.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.